Current Diabetes Reviews

Norman E. Cameron
University of Aberdeen
Aberdeen, Scotland


Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options

Author(s): Nicola Pescosolido, Federica Pranno and Giuseppe Buomprisco

Affiliation: University “Sapienza” of Rome, Faculty of Medicine and Dentistry, Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Viale del Policlinico 155, 00161, Rome, Italy.

Keywords: Anti-VEGF, diabetic macular edema, diabetes, neovascularization, rethinopathy, vision loss prevention.


The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/ grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.

Reprint ePrint Rights & PermissionsPrintExport

Article Details

Page: [491 - 498]
Pages: 8
DOI: 10.2174/15733998113096660083